ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion

Beck V, Herold H, Benge A, Luber B, Hutzler P, Tschesche H, Kessler H, Schmitt M, Geppert HG, Reuning U (2005)

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Beck, V; Herold, H; Benge, A; Luber, B; Hutzler, P; Tschesche, HaraldUniBi; Kessler, H; Schmitt, M; Geppert, HG; Reuning, U
Abstract / Bemerkung
We have recently described that integrin alphavbeta3 upon interaction with its major extracellular matrix ligand vitronectin induces adhesion, motility, and proliferation of human ovarian cancer cells. Due to the important function of alphavbeta3 in cancer cell biology, it has been the effort of many scientific approaches to specifically target alphavbeta3-mediated cell adhesion and tumorbiological effects arising thereof by synthetic integrin antagonists. More recently, proteins of the ADAM family have been recognized as naturally occurring integrin ligands. Among those, human ADAM 15 which encompasses the integrin binding RGD motif was shown to interact with integrin alphavbeta3. Thus, we investigated in human ovarian OV-MZ-6 cancer cells, expressing both ADAM 15 and alphavbeta3, whether ADAM15 might affect alphavbeta3-mediated tumorbiological effects. We stably (over)expressed ADAM15 or its extracellular domain in OV-MZ-6 cells as well as respective ADAM15 mutants containing the tripeptide SGA instead of RGD. Cells (over)expressing ADAM 15-RGD exhibited a significantly reduced alphavbeta3-mediated adhesion to vitronectin. Also, a significant time-dependent decline in numbers of cells cultivated on vitronectin was noticed. This effect was found to be rather due to impaired xvp3-mediated cell adhesion than decreased cell proliferation rates, since de novo DNA synthesis was not significantly altered by elevated ADAM 15 expression. Moreover, a substantially decreased random cellular motility was noticed as a function of ADAM 15 encompassing an intact RGD motif. In conclusion, our results point to a physiological role of ADAM 15 as a natural binding partner of integrin alphavbeta3 thereby loosening tumor cell adhesion to the underlying matrix and regulating tumor cell migration and invasion. (C) 2004 Elsevier Ltd. All rights reserved.
integrin alpha v beta 3; cell adhesion; cell; motility; ADAM15; ovarian cancer
Page URI


Beck V, Herold H, Benge A, et al. ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2005;37(3):590-603.
Beck, V., Herold, H., Benge, A., Luber, B., Hutzler, P., Tschesche, H., Kessler, H., et al. (2005). ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 37(3), 590-603.
Beck, V., Herold, H., Benge, A., Luber, B., Hutzler, P., Tschesche, H., Kessler, H., Schmitt, M., Geppert, H. G., and Reuning, U. (2005). ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 37, 590-603.
Beck, V., et al., 2005. ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 37(3), p 590-603.
V. Beck, et al., “ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion”, INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, vol. 37, 2005, pp. 590-603.
Beck, V., Herold, H., Benge, A., Luber, B., Hutzler, P., Tschesche, H., Kessler, H., Schmitt, M., Geppert, H.G., Reuning, U.: ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 37, 590-603 (2005).
Beck, V, Herold, H, Benge, A, Luber, B, Hutzler, P, Tschesche, Harald, Kessler, H, Schmitt, M, Geppert, HG, and Reuning, U. “ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion”. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 37.3 (2005): 590-603.

35 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases.
Dreymueller D, Theodorou K, Donners M, Ludwig A., Mediators Inflamm 2017(), 2017
PMID: 28260841
Alternative splicing of KAI1 abrogates its tumor-suppressive effects on integrin αvβ3-mediated ovarian cancer biology.
Upheber S, Karle A, Miller J, Schlaugk S, Gross E, Reuning U., Cell Signal 27(3), 2015
PMID: 25435431
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
Gritsina G, Xiao F, O'Brien SW, Gabbasov R, Maglaty MA, Xu RH, Thapa RJ, Zhou Y, Nicolas E, Litwin S, Balachandran S, Sigal LJ, Huszar D, Connolly DC., Mol Cancer Ther 14(4), 2015
PMID: 25646015
Antitumor and anti-angiogenic activity of the recombinant human disintegrin domain of A disintegrin and metalloproteinase 15.
Hou Y, Chu M, Cai Y, Lei J, Chen Y, Zhu R, Gong X, Ma X, Jin J., Mol Med Rep 12(2), 2015
PMID: 25891130
Proteolytic factors in exosomes.
Shimoda M, Khokha R., Proteomics 13(10-11), 2013
PMID: 23526769
Recombinant disintegrin domain of ADAM15 inhibits the proliferation and migration of Bel-7402 cells.
Hou Y, Chu M, Du FF, Lei JY, Chen Y, Zhu RY, Gong XH, Ma X, Jin J., Biochem Biophys Res Commun 435(4), 2013
PMID: 23688428
The glycophorin A transmembrane sequence within integrin αvβ3 creates a non-signaling integrin with low basal affinity that is strongly adhesive under force.
Müller MA, Opfer J, Brunie L, Volkhardt LA, Sinner EK, Boettiger D, Bochen A, Kessler H, Gottschalk KE, Reuning U., J Mol Biol 425(16), 2013
PMID: 23727145
Combined in vivo molecular and anatomic imaging for detection of ovarian carcinoma-associated protease activity and integrin expression in mice.
Hensley HH, Roder NA, O'Brien SW, Bickel LE, Xiao F, Litwin S, Connolly DC., Neoplasia 14(6), 2012
PMID: 22787427
An uPA cleavable conjugate of a recombinant αvβ3 targeting toxin and its bioactivity
Zhu WH, Zhou YL, Sun DJ, Li ZW., World J Microbiol Biotechnol 27(3), 2011
PMID: IND44745649
A new optical imaging probe targeting αVβ3 integrin in glioblastoma xenografts.
Lanzardo S, Conti L, Brioschi C, Bartolomeo MP, Arosio D, Belvisi L, Manzoni L, Maiocchi A, Maisano F, Forni G., Contrast Media Mol Imaging 6(6), 2011
PMID: 22144022
Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins.
Işeri OD, Kars MD, Arpaci F, Gündüz U., Cancer Chemother Pharmacol 65(3), 2010
PMID: 19543729
Enhancement of recombinant human ADAM15 disintegrin domain expression level by releasing the rare codons and amino acids restriction.
Wu J, Zhang L, Lei J, Cai G, Zhu W, Lu D, Jin J., Appl Biochem Biotechnol 157(2), 2009
PMID: 18679595
Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation.
Ruseva Z, Geiger PX, Hutzler P, Kotzsch M, Luber B, Schmitt M, Gross E, Reuning U., Exp Cell Res 315(10), 2009
PMID: 19371633
The role of ADAMs in disease pathophysiology.
Duffy MJ, McKiernan E, O'Donovan N, McGowan PM., Clin Chim Acta 403(1-2), 2009
PMID: 19408347
Identification of binding peptides of the ADAM15 disintegrin domain using phage display.
Wu J, Wu MC, Zhang LF, Lei JY, Feng L, Jin J., J Biosci 34(2), 2009
PMID: 19550037
Integrin alphavbeta3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription.
Lössner D, Abou-Ajram C, Benge A, Aumercier M, Schmitt M, Reuning U., J Cell Physiol 220(2), 2009
PMID: 19334037
Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer.
Kim TJ, Landen CN, Lin YG, Mangala LS, Lu C, Nick AM, Stone RL, Merritt WM, Armaiz-Pena G, Jennings NB, Coleman RL, Tice DA, Sood AK., Cancer Biol Ther 8(23), 2009
PMID: 19829059
Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.
Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M, Foidart JM, Noel A, Cataldo D., Biochimie 90(2), 2008
PMID: 17920749
ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation.
Chen Q, Meng LH, Zhu CH, Lin LP, Lu H, Ding J., Int J Biochem Cell Biol 40(10), 2008
PMID: 18387333
Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.
Landen CN, Kim TJ, Lin YG, Merritt WM, Kamat AA, Han LY, Spannuth WA, Nick AM, Jennnings NB, Kinch MS, Tice D, Sood AK., Neoplasia 10(11), 2008
PMID: 18953435
ADAMs in cancer cell proliferation and progression.
Mochizuki S, Okada Y., Cancer Sci 98(5), 2007
PMID: 17355265
Alpha-v integrins as therapeutic targets in oncology.
Nemeth JA, Nakada MT, Trikha M, Lang Z, Gordon MS, Jayson GC, Corringham R, Prabhakar U, Davis HM, Beckman RA., Cancer Invest 25(7), 2007
PMID: 18027153
ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease.
Kuefer R, Day KC, Kleer CG, Sabel MS, Hofer MD, Varambally S, Zorn CS, Chinnaiyan AM, Rubin MA, Day ML., Neoplasia 8(4), 2006
PMID: 16756724
Multimodality tumor imaging targeting integrin alphavbeta3.
Cai W, Sam Gambhir S, Chen X., Biotechniques 39(6 suppl), 2005
PMID: 20158499

52 References

Daten bereitgestellt von Europe PubMed Central.

Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria.
Arndt M, Lendeckel U, Rocken C, Nepple K, Wolke C, Spiess A, Huth C, Ansorge S, Klein HU, Goette A., Circulation 105(6), 2002
PMID: 11839628
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.
Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP., Nature 385(6618), 1997
PMID: 9034190
Highly enhanced expression of the disintegrin metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue.
Bohm BB, Aigner T, Blobel CP, Kalden JR, Burkhardt H., Arthritis Rheum. 44(9), 2001
PMID: 11592366
Up-regulation of MDC15 (metargidin) messenger RNA in human osteoarthritic cartilage.
Bohm BB, Aigner T, Gehrsitz A, Blobel CP, Kalden JR, Burkhardt H., Arthritis Rheum. 42(9), 1999
PMID: 10513811
Integrin alpha4beta1-dependent adhesion to ADAM 28 (MDC-L) requires an extended surface of the disintegrin domain.
Bridges LC, Hanson KR, Tani PH, Mather T, Bowditch RD., Biochemistry 42(13), 2003
PMID: 12667064
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.
Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA., Cell 79(7), 1994
PMID: 7528107
Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor.
Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA., J. Biol. Chem. 273(43), 1998
PMID: 9774383
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.
Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB., Cancer Res. 47(4), 1987
PMID: 3802100
Human ovarian adenocarcinoma cells synthesize vitronectin and use It to organize their adhesion.
Carreiras F, Cruet S, Staedel C, Sichel F, Gauduchon P., Gynecol. Oncol. 72(3), 1999
PMID: 10053101
Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma.
Emi M, Fujiwara Y, Ohata H, Tsuda H, Hirohashi S, Koike M, Miyaki M, Monden M, Nakamura Y., Genes Chromosomes Cancer 7(3), 1993
PMID: 7687868
RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction.
Eto K, Puzon-McLaughlin W, Sheppard D, Sehara-Fujisawa A, Zhang XP, Takada Y., J. Biol. Chem. 275(45), 2000
PMID: 10944520
Integrin adhesion receptors in tumor metastasis.
Felding-Habermann B., Clin. Exp. Metastasis 20(3), 2003
PMID: 12741679
Integrin signaling.
Giancotti FG, Ruoslahti E., Science 285(5430), 1999
PMID: 10446041
ADAM15 is an adherens junction molecule whose surface expression can be driven by VE-cadherin.
Ham C, Levkau B, Raines EW, Herren B., Exp. Cell Res. 279(2), 2002
PMID: 12243749
Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells.
Hapke S, Kessler H, Arroyo de Prada N, Benge A, Schmitt M, Lengyel E, Reuning U., J. Biol. Chem. 276(28), 2001
PMID: 11331280
Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction.
Hapke S, Kessler H, Luber B, Benge A, Hutzler P, Hofler H, Schmitt M, Reuning U., Biol. Chem. 384(7), 2003
PMID: 12956424
ADAM-mediated shedding and adhesion: A vascular perspective
Herren, News Physiological Sciences 17(), 2002
ADAM15 overexpression in NIH3T3 cells enhances cell-cell interactions.
Herren B, Garton KJ, Coats S, Bowen-Pope DF, Ross R, Raines EW., Exp. Cell Res. 271(1), 2001
PMID: 11697891
Assignment of the ADAM15 gene to human chromosome band 1q21.3 by in situ hybridization.
Karkkainen I, Karhu R, Huovila AP., Cytogenet. Cell Genet. 88(3-4), 2000
PMID: 10828588
Shedding light on sheddases: role in growth and development.
Kheradmand F, Werb Z., Bioessays 24(1), 2002
PMID: 11782944
Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.
Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F., Proc. Natl. Acad. Sci. U.S.A. 96(7), 1999
PMID: 10097139
Intracellular maturation of the mouse metalloprotease disintegrin MDC15.
Lum L, Reid MS, Blobel CP., J. Biol. Chem. 273(40), 1998
PMID: 9748307
The role of ADAM 15 in glomerular mesangial cell migration.
Martin J, Eynstone LV, Davies M, Williams JD, Steadman R., J. Biol. Chem. 277(37), 2002
PMID: 12091380
Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines.
Mobus V, Gerharz CD, Press U, Moll R, Beck T, Mellin W, Pollow K, Knapstein PG, Kreienberg R., Int. J. Cancer 52(1), 1992
PMID: 1500230
Interaction of metargidin (ADAM-15) with alphavbeta3 and alpha5beta1 integrins on different haemopoietic cells.
Nath D, Slocombe PM, Stephens PE, Warn A, Hutchinson GR, Yamada KM, Docherty AJ, Murphy G., J. Cell. Sci. 112 ( Pt 4)(), 1999
PMID: 9914169
Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1 )integrin, leading to a marked induction of fibroblast cell motility.
Nath D, Slocombe PM, Webster A, Stephens PE, Docherty AJ, Murphy G., J. Cell. Sci. 113 ( Pt 12)(), 2000
PMID: 10825303
Expression of ADAM-9 mRNA and protein in human breast cancer.
O'Shea C, McKie N, Buggy Y, Duggan C, Hill AD, McDermott E, O'Higgins N, Duffy MJ., Int. J. Cancer 105(6), 2003
PMID: 12767059
The ADAM gene family: surface proteins with adhesion and protease activity.
Primakoff P, Myles DG., Trends Genet. 16(2), 2000
PMID: 10652535
Processing of the notch ligand delta by the metalloprotease Kuzbanian.
Qi H, Rand MD, Wu X, Sestan N, Wang W, Rakic P, Xu T, Artavanis-Tsakonas S., Science 283(5398), 1999
PMID: 9872749
Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells.
Reuning U, Guerrini L, Nishiguchi T, Page S, Seibold H, Magdolen V, Graeff H, Schmitt M., Eur. J. Biochem. 259(1-2), 1999
PMID: 9914486
Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.
Reuning U, Wilhelm O, Nishiguchi T, Guerrini L, Blasi F, Graeff H, Schmitt M., Nucleic Acids Res. 23(19), 1995
PMID: 7479032
Anchorage dependence, integrins, and apoptosis.
Ruoslahti E, Reed JC., Cell 77(4), 1994
PMID: 8187171
Networks and crosstalk: integrin signalling spreads.
Schwartz MA, Ginsberg MH., Nat. Cell Biol. 4(4), 2002
PMID: 11944032
The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase.
Six E, Ndiaye D, Laabi Y, Brou C, Gupta-Rossi N, Israel A, Logeat F., Proc. Natl. Acad. Sci. U.S.A. 100(13), 2003
PMID: 12794186
Function and interactions of integrins.
van der Flier A, Sonnenberg A., Cell Tissue Res. 305(3), 2001
PMID: 11572082
A family of cellular proteins related to snake venom disintegrins.
Weskamp G, Blobel CP., Proc. Natl. Acad. Sci. U.S.A. 91(7), 1994
PMID: 8146185
ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain.
Wolfsberg TG, Straight PD, Gerena RL, Huovila AP, Primakoff P, Myles DG, White JM., Dev. Biol. 169(1), 1995
PMID: 7750654
ADAMs in fertilization and development.
Wolfsberg TG, White JM., Dev. Biol. 180(2), 1996
PMID: 8954712
Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3.
Zhang XP, Kamata T, Yokoyama K, Puzon-McLaughlin W, Takada Y., J. Biol. Chem. 273(13), 1998
PMID: 9516430
MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin.
Zhou M, Graham R, Russell G, Croucher PI., Biochem. Biophys. Res. Commun. 280(2), 2001
PMID: 11162558


Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®


PMID: 15618016
PubMed | Europe PMC

Suchen in

Google Scholar